SFB-F44 - cell signaling in chronic CNS disorders
Other relevant publications of Josef Marksteiner
2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005
2011
Marksteiner J, Riederer P. (2011)
Prof. Dr. Kurt Jellinger: an appreciation on the occasion of his anniversary.
J Neural Transm. 2011 May;118(5):651. No abstract available.
Willis M, Leitner I, Jellinger KA, Marksteiner J. (2011)
Chromogranin peptides in brain diseases.
J Neural Transm. 2011 May;118(5):727-35. Epub 2011 Apr 30.
Rainer M, Krüger-Rainer C, Eidler F, Fischer P, Marksteiner J. (2011)
Memory clinics in Austria - characteristics and patterns of practice.
Neuropsychiatr. 2011;25(1):9-15. German
Ihl R, Frölich L, Winblad B, Schneider L, Burns A, Möller HJ; WFSBP Task Force on Treatment Guidelines for Alzheimer's Disease and other Dementias. (2011)
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of Alzheimer's disease and other dementias.
World J Biol Psychiatry. 2011 Feb;12(1):2-32.
Frölich L, Ashwood T, Nilsson J, Eckerwall G; Sirocco Investigators. (2011)
Effects of AZD3480 on cognition in patients with mild-to-moderate Alzheimer's disease: a phase IIb dose-finding study.
J Alzheimers Dis. 2011;24(2):363-74.
2010
Pinter G, Likar R, Anditsch M, Bach M, Böhmer F, Friedrich M, Frühwald T, Gosch M, Gugerell M, Lampl C, Marksteiner J, Pietschmann P, Pils K, Schirmer M. (2010)
Problems of pain measurement and pain therapy in the elderly.
Wien Med Wochenschr. 2010 May;160(9-10):235-46.
Defranceso M, Schocke M, Messner HJ, Deisenhammer EA, Hinterhuber H, Marksteiner J, Weiss EM. (2010)
Conversion from MCI (Mild Cognitive Impairment) to Alzheimer's disease: diagnostic options and predictors.
Neuropsychiatr. 2010;24(2):88-98. Review. German.
Ullrich C, Mlekusch R, Kuschnig A, Marksteiner J, Humpel C (2010)
Ubiquitin Enzymes, Ubiquitin and Proteasome Activity in Blood Mononuclear cells of MCI, Alzheimer and Parkinson Patients.
Curr Alzheimer Res., in press
Willis M, Kaufmann WA, Wietzorrek G, Hutter-Paier B, Moosmang S, Humpel C, Hofmann F, Windisch M, Gunther KH, Marksteiner J (2010)
L-Type Calcium Channel Ca{V} 1.2 in Transgenic Mice Overexpressing Human AbetaPP751 with the London (V717I) and Swedish (K670M/N671L) Mutations.
J Alzheimers Dis., in press
Hochstrasser T, Weiss E, Marksteiner J, Humpel C (2010)
Soluble cell adhesion molecules in monocytes of Alzheimer's disease and mild cognitive impairment.
Exp Gerontol 45:70-74.
2009
Defrancesco M, Marksteiner J, Deisenhammer EA, Hinterhuber H, Weiss EM (2009)
Association of Mild Cognitive Impairment (MCI) and depression.
Neuropsychiatr 23:144-150.
Zenzmaier C, Marksteiner J, Kiefer A, Berger P, Humpel C (2009)
Dkk-3 is elevated in CSF and plasma of Alzheimer's disease patients.
J Neurochem 110:653-661.
Marksteiner J, Kemmler G, Weiss EM, Knaus G, Ullrich C, Mechtcheriakov S, Oberbauer H, Auffinger S, Hinterholzl J, Hinterhuber H, Humpel C (2009)
Five out of 16 plasma signaling proteins are enhanced in plasma of patients with mild cognitive impairment and Alzheimer's disease.
Neurobiol Aging.
Kerer M, Marksteiner J, Hinterhuber H, Mazzola G, Steinberg R, Weiss EM (2009)
Dementia and music.
Neuropsychiatr 23:4-14.
Marksteiner J, Humpel C (2009)
Glycogen-synthase kinase-3beta is decreased in peripheral blood mononuclear cells of patients with mild cognitive impairment.
Exp Gerontol 44:370-371.
Schrott-Fischer A, Bitsche M, Humpel C, Walcher C, Maier H, Jellinger K, Rabl W, Glueckert R, Marksteiner J (2009)
Chromogranin peptides in amyotrophic lateral sclerosis.
Regul Pept 152:13-21.
2008
Weiss EM, Kohler CG, Vonbank J, Stadelmann E, Kemmler G, Hinterhuber H, Marksteiner J (2008)
Impairment in emotion recognition abilities in patients with mild cognitive impairment, early and moderate Alzheimer disease compared with healthy comparison subjects.
Am J Geriatr Psychiatry 16:974-980.
Egger K, Schocke M, Weiss E, Auffinger S, Esterhammer R, Goebel G, Walch T, Mechtcheriakov S, Marksteiner J (2008a)
Pattern of brain atrophy in elderly patients with depression revealed by voxel-based morphometry.
Psychiatry Res 164:237-244.
Egger M, Beer AG, Theurl M, Schgoer W, Hotter B, Tatarczyk T, Vasiljevic D, Frauscher S, Marksteiner J, Patsch JR, Schratzberger P, Djanani AM, Mahata SK, Kirchmair R (2008b)
Monocyte migration: a novel effect and signaling pathways of catestatin.
Eur J Pharmacol 598:104-111.
Schmidt R, Neff F, Lampl C, Benke T, Anditsch M, Bancher C, Dal-Bianco P, Reisecker F, Marksteiner J, Rainer M, Kapeller P, Dodel R (2008a)
Therapy of Alzheimer's disease: current status and future development.
Neuropsychiatr 22:153-171.
Marksteiner J, Pirchl M, Ullrich C, Oberbauer H, Blasko I, Lederer W, Hinterhuber H, Humpel C (2008)
Analysis of cerebrospinal fluid of Alzheimer patients. Biomarkers and toxic properties.
Pharmacology 82:214-220.
Kaufmann L, Ischebeck A, Weiss E, Koppelstaetter F, Siedentopf C, Vogel SE, Gotwald T, Marksteiner J, Wood G (2008)
An fMRI study of the numerical Stroop task in individuals with and without minimal cognitive impairment.
Cortex 44:1248-1255.
Schmidt R, Kienbacher E, Benke T, Dal-Bianco P, Delazer M, Ladurner G, Jellinger K, Marksteiner J, Ransmayr G, Schmidt H, Stogmann E, Friedrich J, Wehringer C (2008b)
Sex differences in Alzheimer's disease.
Neuropsychiatr 22:1-15.
Willis M, Prokesch M, Hutter-Paier B, Windisch M, Stridsberg M, Mahata SK, Kirchmair R, Wietzorrek G, Knaus HG, Jellinger K, Humpel C, Marksteiner J (2008)
Chromogranin B and Secretogranin II in transgenic mice overexpressing human APP751 with the London (V717I) and Swedish (K670M/N671L) mutations and in Alzheimer patients.
J Alzheimers Dis 13:123-135.
Karlovec K, Yazdi K, Rier U, Marksteiner J, Aichhorn W (2008)
Separation anxiety disorder and school refusal in childhood: potential risk factors for developing distinct psychiatric disorders?
Prim Care Companion J Clin Psychiatry 10:72-73.
Forstl H, Bickel H, Frolich L, Gertz HJ, Kurz A, Marksteiner J, Monsch AU, Pantel J, Schmidt R, Schonknecht P (2008)
Mild cognitive impairment with predictors of rapid decline.
Dtsch Med Wochenschr 133:431-436.
Marksteiner J, Humpel C (2008)
Beta-amyloid expression, release and extracellular deposition in aged rat brain slices.
Mol Psychiatry 13:939-952.
2007
Aichhorn W, Marksteiner J, Walch T, Zernig G, Hinterhuber H, Stuppaeck C, Kemmler G (2007a)
Age and gender effects on olanzapine and risperidone plasma concentrations in children and adolescents.
J Child Adolesc Psychopharmacol 17:665-674.
Marksteiner J, Hinterhuber H, Humpel C (2007)
Cerebrospinal fluid biomarkers for diagnosis of Alzheimer's disease: beta-amyloid(1-42), tau, phospho-tau-181 and total protein.
Drugs Today (Barc ) 43:423-431.
Jagsch C, Marksteiner J, Seiringer E, Windhager E (2007)
Successful mirtazapine treatment of an 81-year-old patient with syndrome of inappropriate antidiuretic hormone secretion.
Pharmacopsychiatry 40:129-131.
Weiss EM, Stadelmann E, Kohler CG, Brensinger CM, Nolan KA, Oberacher H, Parson W, Pitterl F, Niederstatter H, Kemmler G, Hinterhuber H, Marksteiner J (2007)
Differential effect of catechol-O-methyltransferase Val158Met genotype on emotional recognition abilities in healthy men and women.
J Int Neuropsychol Soc 13:881-887.
Willis M, Hutter-Paier B, Wietzorrek G, Windisch M, Humpel C, Knaus HG, Marksteiner J (2007)
Localization and expression of substance P in transgenic mice overexpressing human APP751 with the London (V717I) and Swedish (K670M/N671L) mutations.
Brain Res 1143:199-207.
Zamarian L, Stadelmann E, Nurk HC, Gamboz N, Marksteiner J, Delazer M (2007)
Effects of age and mild cognitive impairment on direct and indirect access to arithmetic knowledge.
Neuropsychologia 45:1511-1521.
Mechtcheriakov S, Brenneis C, Egger K, Koppelstaetter F, Schocke M, Marksteiner J (2007)
A widespread distinct pattern of cerebral atrophy in patients with alcohol addiction revealed by voxel-based morphometry.
J Neurol Neurosurg Psychiatry 78:610-614.
Aichhorn W, Whitworth AB, Weiss EM, Hinterhuber H, Marksteiner J (2007b)
Differences between men and women in side effects of second-generation antipsychotics.
Nervenarzt 78:45-52.
Blasko I, Knaus G, Weiss E, Kemmler G, Winkler C, Falkensammer G, Griesmacher A, Wurzner R, Marksteiner J, Fuchs D (2007)
Cognitive deterioration in Alzheimer's disease is accompanied by increase of plasma neopterin.
J Psychiatr Res 41:694-701.
2006
Pirchl M, Marksteiner J, Humpel C (2006)
Effects of acidosis on brain capillary endothelial cells and cholinergic neurons: relevance to vascular dementia and Alzheimer's disease.
Neurol Res 28:657-664.
Oberacher H, Pitterl F, Niederstatter H, Weiss EM, Stadelmann E, Marksteiner J, Parson W (2006)
Direct molecular haplotyping of multiple polymorphisms within exon 4 of the human catechol-O-methyltransferase gene by liquid chromatography-electrospray ionization time-of-flight mass spectrometry.
Anal Bioanal Chem 386:83-91.
Aichhorn W, Whitworth AB, Weiss EM, Marksteiner J (2006a)
Second-generation antipsychotics: is there evidence for sex differences in pharmacokinetic and adverse effect profiles?
Drug Saf 29:587-598.
Bitsche M, Schrott-Fischer A, Hinterhoelzl J, Fischer-Colbrie R, Sergi C, Glueckert R, Humpel C, Marksteiner J (2006)
First localization and biochemical identification of chromogranin B- and secretoneurin-like immunoreactivity in the fetal human vagal/nucleus solitary complex.
Regul Pept 134:97-104.
Aichhorn W, Marksteiner J, Walch T, Zernig G, Saria A, Kemmler G (2006b)
Influence of age, gender, body weight and valproate comedication on quetiapine plasma concentrations.
Int Clin Psychopharmacol 21:81-85.
Mechtcheriakov S, Graziadei IW, Kugener A, Schuster I, Mueller J, Hinterhuber H, Vogel W, Marksteiner J (2006)
Motor dysfunction in patients with liver cirrhosis: impairment of handwriting.
J Neurol 253:349-356.
Blasko I, Lederer W, Oberbauer H, Walch T, Kemmler G, Hinterhuber H, Marksteiner J, Humpel C (2006)
Measurement of thirteen biological markers in CSF of patients with Alzheimer's disease and other dementias.
Dement Geriatr Cogn Disord 21:9-15.
2005
Weiss U, Marksteiner J, Kemmler G, Saria A, Aichhorn W (2005a)
Effects of age and sex on olanzapine plasma concentrations.
J Clin Psychopharmacol 25:570-574.
Mechtcheriakov S, Graziadei IW, Kugener A, Wiedemann J, Galbavy C, Hinterhuber H, Marksteiner J, Vogel W (2005a)
Multidimensional assessment of neuro-psychiatric symptoms in patients with low-grade hepatic encephalopathy: a clinical rating scale.
World J Gastroenterol 11:5893-5898.
Weiss EM, Deisenhammer EA, Hinterhuber H, Marksteiner J (2005b)
Gender differences in cognitive functions.
Fortschr Neurol Psychiatr 73:587-595.
Humpel C, Marksteiner J (2005)
Cerebrovascular damage as a cause for Alzheimer's disease.
Curr Neurovasc Res 2:341-347.
Aichhorn W, Weiss U, Marksteiner J, Kemmler G, Walch T, Zernig G, Stelzig-Schoeler R, Stuppaeck C, Geretsegger C (2005)
Influence of age and gender on risperidone plasma concentrations.
J Psychopharmacol 19:395-401.
Mechtcheriakov S, Graziadei IW, Rettenbacher M, Schuster I, Hinterhuber H, Vogel W, Marksteiner J (2005b)
Diagnostic value of fine motor deficits in patients with low-grade hepatic encephalopathy.
World J Gastroenterol 11:2777-2780.
Mechtcheriakov S, Schocke M, Kugener A, Graziadei IW, Mattedi M, Hinterhuber H, Vogel W, Marksteiner J (2005c)
Chemical shift magnetic resonance spectroscopy of cingulate grey matter in patients with minimal hepatic encephalopathy.
Neuroradiology 47:27-34.
